Endogenous acetylcholine in the dorsal hippocampus reduces anxiety through actions on nicotinic and muscarinic receptors

Behavioral Neuroscience

Volumn 112, Issue 2, 1998, Pages 352-359

  File, Sandra E ^a,b   Gonzalez, Luis E ^a   Andrews, Nick ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GUY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; GALLAMINE; MECAMYLAMINE; MUSCARINIC RECEPTOR; NICOTINIC RECEPTOR; PIRENZEPINE;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; HIPPOCAMPUS; MALE; MAZE TEST; NONHUMAN; RAT; SOCIAL INTERACTION;

EID: 0031965891     PISSN: 07357044     EISSN: None     Source Type: Journal    
DOI: 10.1037/0735-7044.112.2.352     Document Type: Article

References (43)

1. 1A receptors in the median raphé nucleus and dorsal hippocampus may mediate anxiolytic and anxiogenic behaviors respectively. European Journal of Pharmacology, 264, 259-264.
2. Balfour, D. J. K., Khullar, K. A., & Longden, A. (1975). Effects of nicotine on plasma corticosterone and brain amines in stressed and unstressed rats. Pharmacology, Biochemistry and Behavior, 3, 349-354.
3. Benwell, M. E. M., Balfour, D. J. K., & Anderson, J. M. (1990). Smoking-associated changes in serotonergic systems of discrete regions of human brain. Psychopharmacology, 102, 68-72.
4. 1 agonist on behavior. Abstracts of the VIIIth Conference of European College of Neuropsychopharmacology, 5, 254.
5. Brioni, J. D., O'Neill, A. B., Kim, D. J., & Decker, M. W. (1993). Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze test. European Journal of Pharmacology, 238, 1-8.
6. Cao, W., Burkholder, T., Wilkins, L., & Collins, A. C. (1993). A genetic comparison of behavioral actions of ethanol and nicotine in the mirrored chamber. Pharmacology, Biochemistry and Behavior, 45, 803-809.
7. 3 receptor antagonist, RS-42358- 197, in animal models of anxiety. European Journal of Pharmacology, 234, 91-99.
8. Curran, H. V., Schifano, F., & Lader, M. (1991). Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood. Psychopharmacology 103, 83-90.
9. Decker, M. W., Brioni, J. D., Sullivan, J. P., Buckley, M. J., Radek, R. J., & Raszkiewicz, J. L. (1994). (S)-3-methyl-5-(l-methyI-2pyrrolidinyl)isoxazole (ABT 418): A novel cholinergic ligand with cognition-enhancing and anxiolytic activities: II. In vivo characterization. Journal of Pharmacology and Experimental Therapeutics, 270, 319-328.
10. Doods, H. N., Mathy, M-J., Davidesko, D., van Charldorp, K. J., & van Zwieten, P. A. (1987). Selectivity of muscarinic antagonists in radioligand and in-vivo experiments for the putative M1, M2 and M3 receptors. Journal of Pharmacology and Experimental Therapeutics, 242, 257-262.
11. El-Bizri, H., & Clarke, P. B. S. (1994). Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine. British Journal of Pharmacology, 113, 917-725.
12. Falter, U., Gower, A., & Gobert, J. (1991). Anxiogenic effects of scopolamine observed in rats in the elevated plus-maze. In M. Briley & S. E. File (Eds.), New concepts in anxiety (pp. 332-337). London; Macmillan Press.
13. Femandes, C., & File, S. E. (1996). The influence of open arm ledges and maze experience in the elevated plus-maze. Pharmacology, Biochemistry and Behavior, 54, 31-40.
14. File, S. E. (1980). The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs. Journal of Neuroscience Methods, 2, 219-238.
15. File, S. E. (1992). Behavioral detection of anxiolytic action. In J. M. Elliott, D. J. Heal, & C. A. Marsden (Eds.), Experimental approaches to anxiety and depression (pp. 25-44). London: Wiley.
16. File, S. E. (1993). The interplay of learning and anxiety in the elevated plus-maze. Behavioral Brain Research, 58, 199-202.
17. 1A-receptor ligands in dorsal raphé and ventral hippocampus. Pharmacology, Biochemistry and Behavior, 54, 123-128.
18. File, S. E., & Zangrossi, H., Jr. (1993). "One-trial tolerance" to the anxiolytic actions of benzodiazepines in the elevated plus-maze, or the development of a phobic state? Psychopharmacology, 110, 240-244.
19. 1A receptor modulation of anxiety in two ethological animal tests. Journal of Neuroscience, 16, 4810-4815.
20. Freund, R. K., Jungsehaffer, D. A., Collins, A. C., & Wehner, J. M. (1988). Evidence for modulation of GABAergic neurotransmission by nicotine. Brain Research, 453, 215-220.
21. 1A and benzodiazepine receptors in the basolateral amygdala modulate anxiety in the social interaction test, but not in the elevated plus-maze. Brain Research, 732, 145-153.
22. Gonzalez, L. E., & File, S. E. (1997). A 5-min experience in the elevated plus-maze alters the state of the benzodiazepine receptor in the dorsal raphé nucleus. Journal of Neuroscience, 17, 1505-1511.
23. Hess, C., & Blozovski, D. (1987). Hippocampal muscarinic cholinergic mediation of spontaneous alternation and fear in the developing rat. Behavioral Brain Research, 24, 203-214.
24. Hodges, H., Green, S., & Glenn, B. (1987). Evidence that the amygdala is involved in benzodiazepine and serotonergic effects on punished responding but not on discrimination. Psychopharmacology, 92, 491-504.
25. 2: muscarinic acetylcholine receptor in the basal forebrain of the rat. Journal of Comparative Neurology, 351, 339-356.
26. Lister, R. G. (1987). The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology, 92, 180-185.
27. Michel, A. D., Delmondo, R. E., Lopez, M., & Whiting, R. L. (1990). On the interaction of gallamine with muscarinic receptor subtypes. European Journal of Pharmacology, 182, 335-345.
28. 1A receptors inhibits carbachol-stimulated inositol 1,4,5trisphosphate mass accumulation in the rodent hippocampus. Neurochemistry Research, 20, 977-983.
29. O'Neill, A. B., & Brioni, J. D. (1994). Benzodiazepine receptor mediation of the anxiolytic-like effect of (-)-nicotine in mice. Pharmacology, Biochemistry and Behavior, 49, 755-757.
30. Paxinos, G., & Watson, C. H. (1986). The rat brain in stereotaxic coordinates. London: Academic Press.
31. Fellow, S., Chopin, P. H., File, S. E., & Briley, M. (1985). Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods, 14, 149-167.
32. Plaznik, A., Jessa, M., Bidzinski, A., & Nazar, M. (1994). The effect of serotonin depletion and intra-hippocampal midazolam on rat behavior in the Vogel conflict test. European Journal of Pharmacology, 257, 293-296.
33. Rodgers, R. J., & Cole, J. (1995). Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety. Behavioral Pharmacology 6, 283-289.
34. Rodgers, R. J., Lee, C., & Shepherd, J. K. (1992). Effects of diazepam on behavioural and antinociceptive reponses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology, 106, 102-110.
35. Rossner, S., Schliebs, R., Perez-Polo, J. R., Wiley, R. G., & Bigl, V. (1995). Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system. Journal of Neuroscience Research, 40, 31-43.
36. Smythe, J. W., Murphy, D., Bhatnagar, S., Timothy, C., & Costall, B. (1996). Muscarinic antagonists are anxiogenic in rats tested in the black-white box. Pharmacology, Biochemistry and Behavior, 54, 57-64.
37. 2 antagonists on in vivo hippocampal acetylcholine levels. Brain Research Bulletin, 41, 221-226.
38. Takayama, H., Majewska, M. D., & London, E. D. (1989). Interaction of noncompetitive inhibitors with nicotinic receptors in rat brain. Journal of Pharmacology and Experimental Therapeutics, 253, 1083-1089.
39. Thorne, B., Irons, J., Lunt, G. G., Wonnacott, S., & Dunkley, P. R. (1987). Comparison of methods for rapid isolation of synaptosomes from brain regions, for uptake and release studies. Biochemical Society Transactions, 16, 309-130.
40. Treit, T., Pesold, C., & Rotzinger, S. (1993). Dissociating the anti-fear effects of septal and amygdaloid lesions using two pharmacologically validated models of rat anxiety. Behavioral Neuroscience, 107, 770-785.
41. Vale, A. L., & Balfour, D. J. K. (1988). Aversive environmental stimuli as a factor in the psychostimulant response to nicotine. Pharmacology, Biochemistry and Behavior, 32, 857-860.
42. Vannucchi, M. G., & Pepeu, G. (1995). Muscarinic receptor modulation of acetylcholine release from rat cerebral cortex and hippocampus. Neuroscience Letters, 190, 53-56.
43. Wonnacott, S., Fryer, L., Lunt, G., Freund, R., Jungschaffen D., & Collins, A. (1987). Nicotinic modulation of GABAergic neurotransmission in the hippocampus. Society for Neuroscience Abstracts, 17, 1352.